Menopause Drug Tied to Breast Cancer Recurrence, VU University Medical Center Research

AHN - A large trial of the drug tibolone, designed to treat menopausal symptoms and bone loss in women, was halted after researchers found the synthetic steroid significantly increased the risk of breast cancer recurring in survivors of the disease.